Jh. Lipton et al., ACUTE MYELOID-LEUKEMIA FOLLOWING THERAPY OF HODGKINS-DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE), Hematological oncology, 14(1), 1996, pp. 29-31
A 26-year-old man developed myelodysplasia rapidly progressing to acut
e myelomonocytic leukemia 3 years after receiving three cycles of ABVD
chemotherapy and upper mantle and upper abdomen radiotherapy for stag
e IA Hodgkin's disease. This represents the fourth such case reported.
The risk of secondary AML after ABVD or radiation therapy is discusse
d.